Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names

INTRODUCTION: The purpose of the present study was to investigate the traceability of adverse events (AEs) for branded and generic drugs with identical nonproprietary names and to consider potential implications for the traceability of AEs for branded and biosimilar biologics. METHODS: Adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Jingdong, Skup, Martha, Alexander, Emily, Tundia, Namita, Macaulay, Dendy, Wu, Eric, Mulani, Parvez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376954/
https://www.ncbi.nlm.nih.gov/pubmed/25772256
http://dx.doi.org/10.1007/s12325-015-0193-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376954/
https://www.ncbi.nlm.nih.gov/pubmed/25772256
http://dx.doi.org/10.1007/s12325-015-0193-5

Ejemplares similares